Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib

Value in Health

Oct 11

Written By Matthijs Versteegh

Oncologypersonalized medicine

Matthijs Versteegh

The economics of patents and innovation in pharma

Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging interventions: a comparison of five European countries